Landos Biopharma Inc. (LABP)
NASDAQ: LABP
· Real-Time Price · USD
22.93
0.13 (0.57%)
At close: May 23, 2024, 10:00 PM
Landos Biopharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -8.9M | -6.12M | -5.86M | -3.92M | -6.03M | -5.23M | -7.9M | -11.28M | -14.86M | -20.1M | -12.6M | 4.1M | -9.82M |
Depreciation & Amortization | n/a | 12K | n/a | n/a | 32K | 1.73M | n/a | 224K | 353K | 55K | 48K | 50K | 43K |
Stock-Based Compensation | 260K | 245K | 248K | 254K | 224K | 196K | 200K | 634K | 941K | 2.43M | 355K | 312K | 1.02M |
Other Working Capital | -48K | 662K | 3.28M | -247K | 1.26M | 1.06M | 1.25M | -2.62M | -288K | 3.04M | 197K | 2.02M | -3.63M |
Other Non-Cash Items | 73K | -1.53M | -3K | 15K | 1.52M | -1.74M | 382K | 223K | 440K | -241K | -110K | -11K | 426K |
Deferred Income Tax | n/a | 1.52M | n/a | n/a | -1.52M | n/a | n/a | n/a | n/a | n/a | 832K | 438K | -178K |
Change in Working Capital | 139K | 905K | 3.39M | -1.46M | -2.39M | 1.35M | -259K | -7.79M | -3.37M | 5.8M | -365K | 4.51M | -4.06M |
Operating Cash Flow | -8.5M | -4.97M | -2.23M | -5.11M | -8.17M | -3.7M | -7.57M | -18M | -16.5M | -12.06M | -11.84M | 9.4M | -12.56M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | -7K | -138K | -35K | -7K | 37K | -264K | -149K | -64K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | 63K | 138K | 35K | 242K | -114K | -121K | n/a | 112K |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | -3.67M | 1K | -2.65M | -1.03M | -8.94M | -80.5M | -4.03M | -81.38M |
Sales Maturities Of Investments | n/a | 63K | 634K | 3.97M | 3.1M | 11.41M | 17.07M | 28.48M | 20.54M | 10.7M | 91.6M | 4.89M | 9.39M |
Other Investing Acitivies | n/a | -57K | n/a | n/a | n/a | 3.68M | 138K | 35K | -242K | 114K | 121K | n/a | -112K |
Investing Cash Flow | n/a | 63K | 634K | 3.97M | 3.1M | 11.47M | 17.21M | 25.87M | 19.51M | 1.8M | 10.83M | 715K | -72.05M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | 19.57M | n/a | n/a | -3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -4.84M | n/a | -99K | 13.67M | n/a | n/a | n/a | n/a | 624K | 219K | n/a | 90.76M |
Financial Cash Flow | n/a | -1.84M | n/a | -99K | 13.67M | n/a | n/a | n/a | n/a | 624K | 219K | n/a | 90.76M |
Net Cash Flow | -8.49M | -4.91M | -1.59M | -1.2M | 8.6M | 7.76M | 9.64M | 7.95M | 2.98M | -9.59M | -794K | 10.12M | 6.16M |
Free Cash Flow | -8.5M | -4.97M | -2.23M | -5.11M | -8.17M | -3.71M | -7.71M | -18.03M | -16.51M | -12.02M | -12.11M | 9.25M | -12.62M |